Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
1.610
+0.090 (5.92%)
At close: Nov 22, 2024, 4:00 PM
1.630
+0.020 (1.25%)
After-hours: Nov 22, 2024, 7:59 PM EST
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $270.16 million as of November 22, 2024. Its market cap has increased by 25.18% in one year.
Market Cap
270.16M
Enterprise Value
208.64M
1-Year Change
25.18%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $270.16M, a decrease of -88.20%. That is a compound annual growth rate of -46.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 266.80M | 13.98% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 262.45M |
| Zynex | 258.27M |
| Lifecore Biomedical | 257.05M |
| Lyell Immunopharma | 255.93M |
| Anika Therapeutics | 255.27M |
| Pulmonx | 253.51M |
| Abeona Therapeutics | 252.41M |
| aTyr Pharma | 250.15M |